Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Acta Neuropathologica Communications|October 20, 2017
Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's caseMarta Marquié, Eline E Verwer, Avery C Meltzer, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2024
Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's DiseasePing Bai, Yu Lan, Yan Liu, et al.
Arquivos De Neuro-Psiquiatria|May 18, 2026
True vignettes: interesting, illustrative examples of behavioral abnormalities in people with Parkinson's diseaseJoseph H Friedman, Umer Akbar, Blake Beehler, et al.
Annals of Neurology|September 8, 2015
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissueMarta Marquié, Marc D Normandin, Charles R Vanderburg, et al.
Neurology|June 17, 2020
β-Glucocerebrosidase activity in <i>GBA</i>-linked Parkinson disease: The type of mutation mattersYoung Eun Huh, Ming Sum Ruby Chiang, Joseph J Locascio, et al.
Neurology|September 27, 2013
Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker StudyHongliu Ding, Kaltra Dhima, Kaitlin C Lockhart, et al.
Nature Communications|September 21, 2022
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degenerationYing Jiang, John J Alam, Stephen N Gomperts, et al.
Annals of Neurology|December 21, 2016
Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathiesMarta Marquié, Marc D Normandin, Avery C Meltzer, et al.
Neurology|April 4, 2020
Research criteria for the diagnosis of prodromal dementia with Lewy bodiesIan G McKeith, Tanis J Ferman, Alan J Thomas, et al.
Pageof 6